- Home
- CGEM vs VINP Comparison
CGEM vs VINP Comparison
Compare CGEM & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- VINP
- Stock Information
- Founded
- CGEM 2016
- VINP 2009
- Country
- CGEM United States
- VINP Brazil
- Employees
- CGEM N/A
- VINP N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- CGEM Health Care
- VINP Finance
- Exchange
- CGEM Nasdaq
- VINP Nasdaq
- Market Cap
- CGEM 530.0M
- VINP 593.2M
- IPO Year
- CGEM 2021
- VINP 2021
- Fundamental
- Price
- CGEM $7.67
- VINP $9.66
- Analyst Decision
- CGEM Strong Buy
- VINP Strong Buy
- Analyst Count
- CGEM 5
- VINP 2
- Target Price
- CGEM $30.00
- VINP $13.25
- AVG Volume (30 Days)
- CGEM 348.1K
- VINP 44.9K
- Earning Date
- CGEM 08-07-2025
- VINP 08-06-2025
- Dividend Yield
- CGEM N/A
- VINP 6.52%
- EPS Growth
- CGEM N/A
- VINP N/A
- EPS
- CGEM N/A
- VINP 0.38
- Revenue
- CGEM N/A
- VINP $126,696,258.00
- Revenue This Year
- CGEM N/A
- VINP $70.28
- Revenue Next Year
- CGEM N/A
- VINP $14.37
- P/E Ratio
- CGEM N/A
- VINP $25.37
- Revenue Growth
- CGEM N/A
- VINP 57.51
- 52 Week Low
- CGEM $6.85
- VINP $8.66
- 52 Week High
- CGEM $21.01
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- CGEM 38.41
- VINP 50.59
- Support Level
- CGEM $8.47
- VINP $9.25
- Resistance Level
- CGEM $9.25
- VINP $9.99
- Average True Range (ATR)
- CGEM 0.45
- VINP 0.26
- MACD
- CGEM -0.12
- VINP 0.01
- Stochastic Oscillator
- CGEM 5.06
- VINP 55.71
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.